CIK 0001133416
- Non-accelerated filer
- Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 043562325
- Phone
- +1 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- 4 Open-market buy Director bought 5,000 shares at $1.71 ($8,550)
- 4 Grant or award President and CEO acquired 10,057 shares (grant or award)
- 4 Open-market buy Director bought 5,000 shares at $1.61 ($8,025)
- 4 Grant or award President and CEO acquired 10,870 shares (grant or award)
- 4 Grant or award President and CEO acquired 10,057 shares (grant or award)
- 4 Grant or award President and CEO acquired 9,358 shares (grant or award)
- 4 Grant or award President and CEO acquired 8,454 shares (grant or award)
- 4 Grant or award Director acquired 17,677 shares (grant or award)
- 4 Open-market sale 10% owner sold 10,000 shares at $2.10 ($21,000)
- 4 Grant or award President and CEO acquired 112,263 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 10 of 39 · 776 filings